Foghorn Therapeutics Inc (FHTX)
6.22
0.00 (0.00%)
USD |
NASDAQ |
May 22, 16:00
6.21
-0.01
(-0.16%)
After-Hours: 20:00
Foghorn Therapeutics Market Cap: 264.88M for May 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 22, 2024 | 264.88M |
| May 21, 2024 | 264.88M |
| May 20, 2024 | 255.51M |
| May 17, 2024 | 234.65M |
| May 16, 2024 | 247.42M |
| May 15, 2024 | 225.28M |
| May 14, 2024 | 241.46M |
| May 13, 2024 | 241.46M |
| May 10, 2024 | 236.78M |
| May 09, 2024 | 252.96M |
| May 08, 2024 | 254.66M |
| May 07, 2024 | 239.76M |
| May 06, 2024 | 248.27M |
| May 03, 2024 | 255.09M |
| May 02, 2024 | 260.20M |
| May 01, 2024 | 249.55M |
| April 30, 2024 | 232.52M |
| April 29, 2024 | 244.02M |
| April 26, 2024 | 233.79M |
| April 25, 2024 | 222.72M |
| April 24, 2024 | 221.87M |
| April 23, 2024 | 219.74M |
| April 22, 2024 | 215.06M |
| April 19, 2024 | 225.70M |
| April 18, 2024 | 235.50M |
| Date | Value |
|---|---|
| April 17, 2024 | 246.14M |
| April 16, 2024 | 256.79M |
| April 15, 2024 | 272.12M |
| April 12, 2024 | 315.99M |
| April 11, 2024 | 340.68M |
| April 10, 2024 | 309.17M |
| April 09, 2024 | 318.54M |
| April 08, 2024 | 305.34M |
| April 05, 2024 | 302.36M |
| April 04, 2024 | 300.23M |
| April 03, 2024 | 307.04M |
| April 02, 2024 | 298.10M |
| April 01, 2024 | 303.64M |
| March 28, 2024 | 285.62M |
| March 27, 2024 | 267.31M |
| March 26, 2024 | 258.38M |
| March 25, 2024 | 252.84M |
| March 22, 2024 | 270.72M |
| March 21, 2024 | 279.66M |
| March 20, 2024 | 276.25M |
| March 19, 2024 | 258.38M |
| March 18, 2024 | 252.42M |
| March 15, 2024 | 251.56M |
| March 14, 2024 | 257.52M |
| March 13, 2024 | 287.75M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
119.24M
Minimum
Feb 05 2024
951.49M
Maximum
Dec 18 2020
411.88M
Average
372.66M
Median
Market Cap Benchmarks
| Viridian Therapeutics Inc | 810.55M |
| CEL-SCI Corp | 70.41M |
| AIM ImmunoTech Inc | 21.05M |
| IGC Pharma Inc | 33.59M |
| NovaBay Pharmaceuticals Inc | 5.289M |
Market Cap Related Metrics
| PS Ratio | 7.731 |
| Price | 6.22 |
| Earnings Yield | -35.37% |